Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Nanoplatform‐Based In Vivo Gene Delivery Systems for Cancer Therapy
Rui Luo, Hao Le, Qinjie Wu, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 16
PHGDH: a novel therapeutic target in cancer
Chae Min Lee, Yeseong Hwang, Minki Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 7, pp. 1513-1522
Open Access | Times Cited: 9
RECQL4 Inhibits Radiation‐Induced Tumor Immune Awakening via Suppressing the cGAS‐STING Pathway in Hepatocellular Carcinoma
Weifeng Hong, Yang Zhang, Siwei Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 7
Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update
Qiang-qiang Fan, Huan Tian, Jiangxue Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117118-117118
Open Access | Times Cited: 5
Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges
Lei Xu, Yuan Cao, XU Ya, et al.
Macromolecular Bioscience (2023) Vol. 24, Iss. 3
Closed Access | Times Cited: 11
Nanoparticles (NPs)-mediated silencing of GSTP1 expression to reverse chemoresistance for effective breast cancer therapy
Qian Shen, Ke Yang, Qingjian Li, et al.
Journal of Colloid and Interface Science (2025) Vol. 685, pp. 38-48
Closed Access
Development of a prognostic model for hepatocellular carcinoma based on microvascular invasion characteristic genes by spatial transcriptomics sequencing
Xiaolan Mu, Lili Pan, Xicheng Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Nanomaterials for liver cancer targeting: research progress and future prospects
Jiahong Xu, Yefu Liu
Frontiers in Immunology (2025) Vol. 16
Open Access
Modulating lipid metabolism by nanoparticles (NPs)-mediated ACSL3 silencing to inhibit hepatocellular carcinoma growth and metastasis
Linzhuo Huang, Rui Xu, Siyu Chen, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Recent advances in optimizing siRNA delivery to hepatocellular carcinoma cells
Ralf Weiskirchen, Sabine Weiskirchen, Chiara Grassi, et al.
Expert Opinion on Drug Delivery (2025)
Closed Access
Self-assembled nanoplatform-mediated co-delivery of brusatol to sensitize sorafenib for hepatocellular carcinoma treatment
Fengrui Liu, Senlin Li, Chengcheng Huang, et al.
RSC Advances (2025) Vol. 15, Iss. 15, pp. 11675-11687
Open Access
Inhibition of KIAA1429/HK1 axis enhances the sensitivity of liver cancer cells to sorafenib by regulating the Warburg effect
Dong Liu, Meihua Shan, Rong Zeng, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116419-116419
Closed Access | Times Cited: 2
Omics‐Enhanced Nanomedicine for Cancer Therapy
Lin Qi, Zhihong Li, Jianping Liu, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 2
Targeting PTGDS Promotes ferroptosis in peripheral T cell lymphoma through regulating HMOX1-mediated iron metabolism
Shunfeng Hu, Bingyu Liu, Juanjuan Shang, et al.
British Journal of Cancer (2024)
Open Access | Times Cited: 2
Identifying Proteins and Amino Acids Associated with Liver Cancer Risk: A Study Utilizing Mendelian Randomization and Bulk RNA Sequencing Analysis
Chi Ma, Ling Tang, Jiaqi Yao, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 262-262
Open Access | Times Cited: 1
Identification of an immune-related gene signature for predicting prognosis and immunotherapy efficacy in liver cancer via cell-cell communication
Juntao Li, Hongmei Zhang, Wei Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 11, pp. 1609-1620
Open Access | Times Cited: 1
LncRNA FAISL Inhibits Calpain 2‐Mediated Proteolysis of FAK to Promote Progression and Metastasis of Triple Negative Breast Cancer
Yunmei Zhang, Shiyu Wei, Zhengjie Chen, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
LncOCMRL1 promotes oral squamous cell carcinoma growth and metastasis via the RRM2/EMT pathway
Nan Lü, Qiming Jiang, Tianshu Xu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Nanoparticle-mediated efficient up-regulation of GSDMD-N to induce pyroptosis and enhance NK cell-based cancer immunotherapy
Zixian Huang, Chunfang Wei, Yi Chen, et al.
Acta Biomaterialia (2024)
Closed Access | Times Cited: 1
Cancer metabolic reprogramming and precision medicine-current perspective
Tingting Gao, Liuxin Yang, Yali Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Ferric‐Tannic Nanoparticles Inhibit Early‐Stage Hepatocarcinogenesis by Activating Tumor Immune Responses in Rats
Jannarong Intakhad, Arpamas Vachiraarunwong, Rawiwan Wongpoomchai, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 12
Closed Access
Page 1

Scroll to top